QLi5 Therapeutics GmbH announced a private placement of 200,000 common shares of face value KRW 1,359.41 at a price of KRW 10,195.575 price per share for gross proceeds of KRW 2,039,115,000 on June 11, 2020. The transaction will include participation from returning investor Qurient Co., Ltd. (KOSDAQ:A115180). The shares are being issued at premium through third party allocation. The payment date is June 30, 2020. Prior to the transaction, the Total number of shares issued are 260,000.